Gout affecting the hand and wrist

Journal of the American Academy of Orthopaedic Surgeons

Volumn 15, Issue 10, 2007, Pages 625-635

  Fitzgerald, Brian T ^a   Setty, Arathi ^b   Mudgal, Chaitanya S ^b,c,d  

^a NAVAL MEDICAL CENTER SAN DIEGO   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d Hand Surgery Fellowship   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 35548998336     PISSN: 1067151X     EISSN: None     Source Type: Journal    
DOI: 10.5435/00124635-200710000-00007     Document Type: Conference Paper

References (49)

1. Mikuls TR, Farrar JT, Bilker WB, Fernandes S, Schumacher HR, Saag KG: Gout epidemiology: Results from the UK General Practice Research Database, 1990-1999. Ann Rheum Dis 2005;64:267-272.
2. Kramer HM, Curhan G: The association between gout and nephrolithiasis: The National Health and Nutrition Examination Survey III, 1988-1994. Am J Kidney Dis 2002;40:37-42.
3. Bieber JD, Terkeltaub RA: Gout: On the brink of novel therapeutic options for an ancient disease. Arthritis Rheum 2004;50:2400-2414.
4. Arromdee E, Michet CJ, Crowson CS, O'Fallon WM, Gabriel SE: Epidemiology of gout: Is the incidence rising? J Rheumatol 2002;29:2403-2406.
5. Macfarlane DG, Dieppe PA: Diuretic-induced gout in elderly women. Br J Rheumatol 1985;24:155-157.
6. ter Borg EJ, Rasker JJ: Gout in the elderly, a separate entity? Ann Rheum Dis 1987;46:72-76.
7. Wernick R, Winkler C, Campbell S: Tophi as the initial manifestation of gout: Report of six cases and review of the literature. Arch Intern Med 1992;152:873-876.
8. Simkin PA, Campbell PM, Larson EB: Gout in Heberden's nodes. Arthritis Rheum 1983;26:94-97.
9. Wu XW, Muzny DM, Lee CC, Caskey CT: Two independent mutational events in the loss of urate oxidase during hominoid evolution. J Mol Evol 1992;34:78-84.
10. Mudgal CS: Management of tophaceous gout of the distal interphalangeal joint. J Hand Surg [Br] 2006;31:101-103.
11. Boss GR, Seegmiller JE: Hyperuricemia and gout: Classification, complications and management. N Engl J Med 1979;300:1459-1468.
12. Campbell SM: Gout: How presentation, diagnosis, and treatment differ in the elderly. Geriatrics 1988;43:71-77.
13. Straub LR, Smith JW, Carpenter GK, Dietz GH: The surgery of gout in the upper extremity. J Bone Joint Surg Am 1961;43:731-752.
14. Linton RR, Talbott JH: The surgical treatment of tophaceous gout. Ann Surg 1943;117:161-182.
15. Larmon WA: Surgical management of tophaceous gout. Clin Orthop Relat Res 1970;71:56-69.
16. Moore JR, Weiland AJ: Gouty tenosynovitis in the hand. J Hand Surg [Am] 1985;10:291-295.
17. Kumar S, Gow P: A survey of indications, results and complications of surgery for tophaceous gout. N Z Med J 2002,115:U109.
18. Holland NW, Jost D, Beutler A, Schumacher R, Agudelo CA: Finger pad tophi in gout. J Rheumatol 1996;23:690-692.
19. Caudle RJ, Heim JM, Stern PJ: Digital flexion contractures secondary to tophaceous gout: A report of three cases. Orthopedics 1989;12:731-735.
20. Weniger FG, Davison SP, Risin M, Salyapongse AN, Manders EK: Gouty flexor tenosynovitis of the digits: Report of three cases. J Hand Surg [Am] 2003;28:669-672.
21. Cassagrande PA: Surgery of tophaceous gout. Semin Arthritis Rheum 1972;1:262-272.
22. Mockford BJ, Kincaid RJ, Mackay I: Carpal tunnel syndrome secondary to intratendinous infiltration by tophaceous gout. Scand J Plast Reconstr Surg Hand Surg 2003;37:186-187.
23. Chuang HL, Wong CW: Carpal tunnel syndrome induced by tophaceous deposits on the median nerve: Case report. Neurosurgery 1994;34:919-920.
24. Ogilvie C, Kay NR: Fulminating carpal tunnel syndrome due to gout. J Hand Surg [Br] 1988;13:42-43.
25. Pai CH, Tseng CH: Acute carpal tunnel syndrome caused by tophaceous gout. J Hand Surg [Am] 1993;18:667-669.
26. Rich JT, Bush DC, Lincoski CJ, Harrington TM: Carpal tunnel syndrome due to tophaceous gout. Orthopedics 2004;27:862-863.
27. Akizuki S, Matsui T: Entrapment neuropathy caused by tophaceous gout. J Hand Surg [Br] 1984;9:331-332.
28. Green EJ, Dilworth JH, Levitin PM: Tophaceous gout: An unusual cause of bilateral carpal tunnel syndrome. JAMA 1977;237:2747-2748.
29. Janssen T, Rayan GM: Gouty tenosynovitis and compression neuropathy of the median nerve. Clin Orthop Relat Res 1987;216:203-206.
30. Pledger SR, Hirsch B, Freiberg RA: Bilateral carpal tunnel syndrome secondary to gouty tenosynovitis: A case report. Clin Orthop Relat Res 1976; 118:188-189.
31. Weinzweig J, Fletcher JW, Linburg RM: Flexor tendinitis and median nerve compression caused by gout in a patient with rheumatoid arthritis. Plast Reconstr Surg 2000;106:1570-1572.
32. Popp JD, Bidgood WD, Edwards NL: Magnetic resonance imaging of tophaceous gout in the hands and wrists. Semin Arthritis Rheum 1996;25:282-289.
33. Jbara M, Patnana M, Kazmi F, Beltran J: MR imaging: Arthropathies and infectious conditions of the elbow, wrist and hand. Radiol Clin North Am 2006;44:625-642.
34. Schlesinger N: Management of acute and chronic gouty arthritis: Present state-of-the-art. Drugs 2004;64:2399-2416.
35. Allison MC, Howatson AG, Torrance CJ, Lee FD, Russell RI: Gastrointestinal damage associated with the use of nonsteroidal antiinflammatory drugs. N Engl J Med 1992;327:749-754.
36. Sandler DP, Burr FR, Weinberg CR: Nonsteroidal anti-inflammatory drugs and the risk for chronic renal disease. Ann Intern Med 1991;115:165-172.
37. Ahern MJ, Reid C, Gordon TP, Mc-Credie M, Brooks PM, Jones M: Does colchicine work? Results of the first controlled study in acute gout. Aust N Z J Med 1987;17:301-304.
38. Emmerson BT: The management of gout. N Engl J Med 1996;334:445-451.
39. Borstad GC, Bryant LR, Abel MP, Scroggie DA, Harris MD, Alloway JA: Colchicine for prophylaxis of acute flares when initiating allopurinol for chronic gouty arthritis. J Rheumatol 2004;31:2429-2432.
40. Singer JZ, Wallace SL: The allopurinol hypersensitivity syndrome: Unnecessary morbidity and mortality. Arthritis Rheum 1986;29:82-87.
41. Swan S, Khosravan R, Mayer MD, et al: Effect of renal impairment on pharmacokinetics, pharmacodynamics, and safety of febuxostat (TMX-67): A novel non-purine selective inhibitor of xanthine oxidase. Arthritis Rheum 2003, 48(suppl):S529.
42. Becker MA, Schumacher R, Wortmann R, et al: Febuxostat: A novel nonpurine selective inhibitor of xanthine oxidase in allopurinol intolerant patients. Arthritis Rheum 2004, 50(suppl):S336.
43. Choi HK, Atkinson K, Karlson EW, Willett W, Curhan G: Alcohol intake and risk of incident gout in men: A prospective study. Lancet 2004;363: 1277-1281.
44. Choi HK, Liu S, Curhan G: Intake of purine-rich foods, protein, and dairy products and relationship to serum levels of uric acid: The Third National Health and Nutrition Examination Survey. Arthritis Rheum 2005;52: 283-289.
45. Choi HK, Atkinson K, Karlson EW, Willett W, Curhan G: Purine-rich foods, dairy and protein intake, and the risk of gout in men. N Engl J Med 2004;350:1093-1103.
46. Choi HK, Mount DB, Reginato AM, American College of Physicians, American Physiological Society: Pathogenesis of gout. Ann Intern Med 2005, 143:499-516.
47. Choi HK, Atkinson K, Karlson EW, Curhan G: Obesity, weight change, hypertension, diuretic use, and risk of gout in men: The health professionals follow-up study. Arch Intern Med 2005;165:742-748.
48. Gelberman RH, Doty DH, Hamer ML: Tophaceous gout involving the proximal interphalangeal joint. Clin Orthop Relat Res 1980;147:225-227.
49. Larmon WA, Kurtz JF: The surgical management of chronic tophaceous gout. J Bone Joint Surg Am 1958;40: 743-772.